Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.250 Biomarker group BEFREE Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension. 31354700 2019
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.250 GeneticVariation group BEFREE There was no association of hypertension with IL1RN genotype. 21840356 2011
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.250 Biomarker group LHGDN Association study of two interleukin-1 gene loci with essential hypertension in a Pakistani Pathan population. 17611547 2008
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.250 GeneticVariation group LHGDN In conclusion, no association of the IL1B C(- 31)T with HT was found, whereas combined frequency of the minor alleles of the IL1RN polymorphism was increased in the HT cohort studied. 11840488 2002
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.250 GeneticVariation group BEFREE In conclusion, no association of the IL1B C(- 31)T with HT was found, whereas combined frequency of the minor alleles of the IL1RN polymorphism was increased in the HT cohort studied. 11840488 2002
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.250 Biomarker group RGD We observed that: (1) intracerebral ventricular injection of (ICV) IL-1beta induced pressor responses; (2) hypertension induced by IL-1beta was blocked by ICV an IL-1 antagonist, IL-1ra; (3) ICV IL-1ra attenuated the pressor response induced by FS but intravenous injection of IL-1ra did not significantly reduce this response; (4) the hypertensive response to conditioned fear stimuli was reversed by ICV IL-1ra; (5) FS-induced-analgesia was attenuated by ICV IL-1ra and this effect disappeared 15 min after ICV IL-1ra. 11585563 2001
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.250 Biomarker group BEFREE We postulated that chronic treatment with a recombinant human interleukin-1 receptor antagonist (IL-1ra) would inhibit development of chronic pulmonary hypertension in animal models. 7946395 1994